相关实验视频

Updated: Jul 15, 2025

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

抗体-药物结合在乳腺癌:当前状态和未来方向

Cynthia Mark¹, Jin Sun Lee¹, Xiaojiang Cui²

¹Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

International journal of molecular sciences

|September 28, 2023

概括

抗体药物联合体 (ADC) 通过将抗体与药物结合,提供向癌症治疗. 研究正在探索最佳的测序和克服抵抗,以改善乳腺癌治疗.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
生物技术是生物技术.

背景情况:

抗体药物联合体 (ADCs) 代表了癌症治疗的重大进步,将向抗体输送与强大的细胞毒剂相结合.
与传统化疗相比,ADCs旨在通过选择性向癌细胞来提高治疗疗效,同时最大限度地降低全身毒性.

研究的目的:

审查抗体药物联合体 (ADC) 在癌症治疗,特别是乳腺癌当前的情况.
解决关键挑战,包括ADC的最佳测序和克服治疗耐药性.
探索新的治疗策略,包括组合疗法和个性化医疗方法.

主要方法:

对抗体药物合物 (ADCs) 的最新临床发展和临床前研究的审查.
分析新出现的抵抗机制以及克服它们的潜在策略.
探索个性化药物和分子分析,以量身定制ADC选择.

主要成果:

像T-DXd和sacituzumab govitecan这样的ADC在治疗特定乳腺癌亚型 (HER2-低和三阴性乳腺癌) 中表现出显著的影响.
临床前数据表明,与免疫检查点抑制剂 (ICI) 和氨酸激酶抑制剂 (TKI) 的结合方法可能会提高ADC的有效性.
基于分子分析的个性化治疗策略显示出优化ADC治疗的前景.

结论:

抗体药物联合体 (ADCs) 正在彻底改变癌症治疗,为挑战乳腺癌等恶性瘤提供了新的希望.
进一步的研究至关重要,以建立最佳的治疗顺序和组合策略,以克服耐药性.
个性化医疗是最大限度地提高ADC的好处和最大限度地减少患者特异性的副作用的关键.

关键词:

抗体药物联合体抗体药物联合体乳腺癌乳腺癌乳腺癌药物耐药性耐药性药物耐药性

更多相关视频

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...